New Delhi: Lauding the final approval of the Drugs Controller General of India (DCGI) on Sunday to two COVID-19 vaccines, All India Institute Of Medical Science (AIIMS) Director Randeep Guleria said, the indigenously developed Covaxin, one of the two vaccines approved, can be used as a backup.
“It’s a great day for our country and it’s a very good way to start the new year. Both the vaccines are made in India. They are cost-effective & easy to administer. We should, in a very short period, start rolling out vaccines,” Hindustan Times (HT) quoted him as saying.
Vaccines go through various stages to make sure it’s safe. All data is critically looked at by experts after which vaccine is approved, the AIIMS director further added.
He said that the vaccine developed by Bharat Biotech will be used as a backup. “In an emergency situation when there is a sudden increase in cases & we need to vaccinate, Bharat Biotech vaccine will be used. It can also be used as a backup when we’re not sure how efficacious the Serum Institute vaccine is going to be,” Guleria was quoted as saying.
ALSO READ: India Gets COVID Vaccine: SII & Bharat Biotech Candidates Formally Approved
ALSO READ: Adar Poonawalla Thanks PM Modi, DCGI After Covishield Gets Final Approval
Mumbai: Abhishek Bachchan’s highly-anticipated film ‘I Want To Talk’ released in theatres on Friday, and the…
New Delhi: Accused of giving cash to secure votes ahead of election day in Maharashtra,…
Bhubaneswar: Chief Minister Mohan Charan Majhi attended the ‘Odisha State Day Celebrations’ at the 43rd…
Mumbai: Recently, some morphed pictures of actress Shweta Tiwari and her good friend Vishal Aditya…
Phulbani: Two tribal men were sentenced to life imprisonment by a special court in Odisha's…
New Delhi: It’s been just over two months since Atishi took oath as Delhi’s chief…
Bhubaneswar: In a moment of pride for AIIMS Bhubaneswar, Dr Manita Tamang, a final-year Senior…
Imphal: In view of the surge in violence in troubled Manipur, the Central government will send…